017). Topline results were announced from a phase 3 trial evaluating AXS-12 (reboxetine) in patients with narcolepsy. AXS-12 is an investigational highly selective potent norepinephrine reuptake ...

Find effective medications for 'Narcolepsy treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to manage ...

Narcolepsy is a nervous system disorder that involves your brain. You struggle to manage sleep patterns and stay awake. No matter how much rest you got the night before, an intense urge to sleep ...

For years, Jazz Pharmaceuticals has dominated the market in treating narcolepsy with cataplexy. But increased competition is on the horizon. Classic treatment options ...

Some volunteers who tried the narcolepsy treatment ... voice" before developing laryngeal dystonia Botox (botulinum toxin) injections are often used to treat LD but are ineffective for up to ...

Axsome's AXS-12 met its primary endpoint in a Phase 3 study, significantly reducing cataplexy attacks in narcolepsy patients, positioning it for an NDA submission. The narcolepsy market is ...

Some volunteers who tried the narcolepsy treatment ... Botox (botulinum toxin) injections are often used to treat LD but are ineffective for up to 40% of patients, the researchers, from the ...

The new research was done with rhesus monkeys and may have therapeutic implications for people who suffer from narcolepsy and ... orexin-A (either intravenous injection or nasal spray) immediately ...